Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Tumor Treating Fields (TTFields) Combined With Chemoradiation in Newly Diagnosed Glioblastoma (Unity)

NCT03705351 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.

NCT NCT03705351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03705351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Tumor Treating Fields (TTFields) Combined With Chemoradiation in Newly Diagnosed Glioblastoma (Unity)
Lead sponsor
Providence Health & Services
Phase
Phase 1
Overall status
Terminated
Start date
December 2, 2019
Completion date
February 24, 2022
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, cancer of brain, glioblastoma, glioblastoma multiforme